Latest Blogs

Feb 04, 2020
World Cancer Day 2020 is about every one of us, and about asking for our commitment to do something to prevent cancer and support people and communities deal with cancer.
Jan 30, 2020
We can’t do a great job caring for our patients if we are spreading ourselves too thin, writes Dr. Sayeh Lavasani.
Jan 28, 2020
Dr. Inas Abuali confronts that pesky inner voice that occasionally whispers, "You don't really belong here." 
Jan 28, 2020
My interests in education and global oncology have allowed me to connect with great people. One of them is Dr. Julie Gralow, a fierce advocate for global oncology and an international expert in breast cancer.
Subscribe to this column

Clifford A. Hudis, MD, FACP, FASCO

Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO. Prior to this role, he served as chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a past president of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.

Mar 27, 2014
As you read this, our 50th Annual Meeting is rapidly approaching. Tens of thousands of travelers are planning their time in Chicago, and hundreds of presenters and discussants are finalizing their posters and slides while many more ASCO volunteers and staff are making final preparations to...
Jan 27, 2014
The approach of ASCO’s Annual Meeting—where we will celebrate the 50th year since our founding in 1964—brings excitement and anticipation. Your Cancer Education Committee, led by Dr. Gini Fleming, has been working hard and in collaboration with the...
Nov 12, 2013
Sometimes life and events unfold in ways that suggest the presence of planning and forethought. It is hard to be sure since, faced with randomness and coincidence, some have suggested that we have been selected through evolution to see patterns and associations even when none exist.
Oct 04, 2013
This week I had the good fortune to attend the 10th Main Meeting of the Early Breast Cancer Trialists’ Collaborative Group in Oxford, England. Known widely as “the meta-analysis” or as the “Oxford Overview,” this effort has relied on very large numbers (of randomly assigned patients) to fuel the...
Jul 25, 2013
There are a large number of great scientific and educational meetings to choose from, but the 2013 Breast Cancer Symposium, Saturday, September 7 to Monday, September 9, in San Francisco is unique. It is big enough to draw clinical and translational experts in all disciplines and informal enough to...

Pages